Perjeta Approved for Late-Stage Breast Cancer

Perjeta Approved for Late-stage Breast Cancer

Filed under: Drug Treatment Help Washington D.C.

Washington, DC – infoZine – The US Food and Drug Administration approved Perjeta (pertuzumab), a new anti-HER2 therapy, to treat patients with HER2-positive late-stage (metastatic) breast cancer. Intended for patients who have not received prior …
Read more on Kansas City infoZine

Johnson & Johnson plans 0 million charge linked to Risperdal sales

Filed under: Drug Treatment Help Washington D.C.

The hefty charge would also fund potential settlements for litigation involving marketing of Invega, another J&J schizophrenia treatment, as well as Natrecor, a medicine for congestive heart failure. The money being set aside would also help cover …
Read more on Chicago Tribune

Johnson & Johnson plans 0 million charge linked to Risperdal sales

Filed under: Drug Treatment Help Washington D.C.

The hefty charge would also fund potential settlements for litigation involving marketing of Invega, another J&J schizophrenia treatment, as well as Natrecor, a medicine for congestive heart failure. The money being set aside would also help cover …
Read more on Reuters